BIOCAD Company and KOÇAK FARMA Sign a Definitive Agreement on Rituximab Healthcare Global A Definitive Agreement on export of rituximab API produced by CJSC BIOCAD to Turkey was signed on August 13th, 2013 between CJSC BIOCAD and KOÇAK FARMA, a leading Turkish pharmaceutical company with strong presence in the area of oncology. |
